Business Description
Themis Medicare Ltd
ISIN : INE083B01024
Share Class Description:
BOM:530199: Shs DematerialisedCompare
Compare
Traded in other countries / regions
THEMISMED.India IPO Date
2000-05-19Description
Themis Medicare Ltd is an Indian based company engaged in the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India and also has a presence in the international market. Its product categories include Anti Malarial, CCD products, Nutritional Gummies, and Candy and Other Products such as OD-LM, Dexem, Medzol and Tazowin.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.29 | |||||
| Equity-to-Asset | 0.66 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 1.26 | |||||
| Interest Coverage | 4.88 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7.81 | |||||
| Beneish M-Score | -1.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.6 | |||||
| 3-Year EBITDA Growth Rate | 25.2 | |||||
| 3-Year EPS without NRI Growth Rate | 31.6 | |||||
| 3-Year FCF Growth Rate | -32.1 | |||||
| 3-Year Book Growth Rate | 22.8 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31 | |||||
| 9-Day RSI | 36.48 | |||||
| 14-Day RSI | 40.68 | |||||
| 6-1 Month Momentum % | 34.39 | |||||
| 12-1 Month Momentum % | 57.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.91 | |||||
| Quick Ratio | 1.51 | |||||
| Cash Ratio | 0.18 | |||||
| Days Inventory | 174.17 | |||||
| Days Sales Outstanding | 155 | |||||
| Days Payable | 108.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.24 | |||||
| Dividend Payout Ratio | 0.1 | |||||
| Forward Dividend Yield % | 0.24 | |||||
| 5-Year Yield-on-Cost % | 0.24 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | -0.54 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 64.86 | |||||
| Operating Margin % | 11.18 | |||||
| Net Margin % | 12.44 | |||||
| FCF Margin % | -3.48 | |||||
| ROE % | 13.3 | |||||
| ROA % | 8.88 | |||||
| ROIC % | 7.7 | |||||
| ROC (Joel Greenblatt) % | 19.28 | |||||
| ROCE % | 16.95 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 43.91 | |||||
| PE Ratio without NRI | 43.95 | |||||
| Shiller PE Ratio | 46.67 | |||||
| Price-to-Owner-Earnings | 135.1 | |||||
| PEG Ratio | 0.84 | |||||
| PS Ratio | 5.46 | |||||
| PB Ratio | 5.45 | |||||
| Price-to-Tangible-Book | 5.35 | |||||
| Price-to-Operating-Cash-Flow | 123.57 | |||||
| EV-to-EBIT | 31.76 | |||||
| EV-to-EBITDA | 26.71 | |||||
| EV-to-Revenue | 5.53 | |||||
| EV-to-FCF | -162.2 | |||||
| Price-to-Projected-FCF | 5.77 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.72 | |||||
| Price-to-Graham-Number | 3.01 | |||||
| Price-to-Net-Current-Asset-Value | 19.3 | |||||
| Earnings Yield (Greenblatt) % | 3.15 | |||||
| FCF Yield % | -0.65 | |||||
| Forward Rate of Return (Yacktman) % | 20.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Themis Medicare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 3,640.48 | ||
| EPS (TTM) (₹) | 4.914 | ||
| Beta | 0.88 | ||
| Volatility % | 50.78 | ||
| 14-Day RSI | 40.68 | ||
| 14-Day ATR (₹) | 10.334032 | ||
| 20-Day SMA (₹) | 220.2975 | ||
| 12-1 Month Momentum % | 57.86 | ||
| 52-Week Range (₹) | 131.34 - 259.75 | ||
| Shares Outstanding (Mil) | 92.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Themis Medicare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Themis Medicare Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Themis Medicare Ltd Frequently Asked Questions
What is Themis Medicare Ltd(BOM:530199)'s stock price today?
The current price of BOM:530199 is ₹211.30. The 52 week high of BOM:530199 is ₹259.75 and 52 week low is ₹131.34.
When is next earnings date of Themis Medicare Ltd(BOM:530199)?
The next earnings date of Themis Medicare Ltd(BOM:530199) is .
Does Themis Medicare Ltd(BOM:530199) pay dividends? If so, how much?
The Dividend Yield %  of Themis Medicare Ltd(BOM:530199) is 0.24% (As of Today), Highest Dividend Payout Ratio of Themis Medicare Ltd(BOM:530199) was 0.1. The lowest was 0.05. And the median was 0.05. The  Forward Dividend Yield % of Themis Medicare Ltd(BOM:530199) is 0.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers